Alliance Santé Planétaire14h ago
Journalisme d'investigation #ICIJ #CIJI face à l'opacité du #LobbyPharmaceutique #BigPharma https://www.icij.org/investigations/cancer-calculus/patents-prices-and-court-files-how-icij-used-data-to-investigate-an-industry-that-thrives-on-secrecy/ #Merci #MSD #Keytruda @icij @cnge_france #CMG
Patents, prices and court files: How ICIJ used data to investigate an industry that thrives on secrecy - ICIJ

For the Cancer Calculus, ICIJ’s data team created datasets using records from patent offices and courts, and analyzed the opaque pricing of a lifesaving drug with a sky-high price tag.

International Consortium of Investigative Journalists
Gute Pillen – Schlechte PillenApr 14

Das Beispiel des #Krebsmedikaments #Keytruda (Wirkstoff #Pembrolizumab) verdeutlicht, dass die hohen Forschungskosten, mit denen die Pharmaindustrie hohe Preise begründet, oft nur vorgeschoben sind

https://www.zdfheute.de/politik/deutschland/krebs-medikament-kosten-pharmakonzerne-krankenkassen-100.html

Die Gesellschaft zahlt doppelt

https://gutepillen-schlechtepillen.de/pharmaindustrie-profit-mit-oeffentlichen-mitteln/

Keytruda: Medikament gegen Krebs wird zum Systemsprenger

Keytruda ist das umsatzstärkste Medikament der Welt. Die Gesundheitskosten für das Krebsmittel kletterten in Deutschland allein im letzten Jahr auf mehr als zwei Milliarden Euro.

ZDFheute
cobJan 3

Faut réduire la #securitesociale et fliquer les médecins qui prescrivent des arrêts maladies aux non-politiciens/miliardaires car ça coûte trop cher :

https://www.quechoisir.org/enquete-medicaments-braquage-pharmaceutique-n171088

Labo #MSD #Novartis

= pénurie de médicaments 'anciens' génériques/vieux brevêt cf #paracetamol

#sante #politique #economie #corruption #pembrolizumab #keytruda #monopole #zolgensma #vyndaqel #business

Prix des médicaments - Braquage pharmaceutique - Enquête

Les prix des nouveaux traitements sont devenus si exorbitants qu’ils mettent en péril l’accès aux soins. Illustration avec le numéro 1 des dépenses de santé en France, le Keytruda, un anticancéreux emblématique des dérives du système.

UFC-Que Choisir
Tin hot mỗi ngàyNov 13, 2025

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nh ất thế giới

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nhất thế giới 💖👉🍀🍀🤔 #ungthu #Keytruda #miendich #Merck #biosimilar #suckhoe 1️⃣ Vị thế số một của Keytruda trên thị trường toàn cầu 

Trong vòng một thập niên, Keytruda (Pembrolizumab) của Merck đã tạo nên kỷ lục hiếm có: doanh thu vượt 146 tỷ USD, trở thành thuốc ung thư bán chạy nhất thế giới.

https://tinmoitrongngay2.wordpress.com/2025/11/13/%f0%9f%8c%bf-toan-canh-keytruda-thuoc-ung-thu-ban-chay-nh-at-the-gioi-2/

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nh ất thế giới

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nhất thế giới 💖👉🍀🍀🤔 #ungthu #Keytruda #miendich #Merck #biosimilar #suckhoe 1️⃣ Vị thế số một của Keytruda trên thị trường toàn cầu 

Trong vòng một th…

Tin mới trong ngày
Tin hot mỗi ngàyNov 13, 2025

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nh ất thế giới

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nhất thế giới 💖👉🍀🍀🤔 #ungthu #Keytruda #miendich #Merck #biosimilar #suckhoe 1️⃣ Vị thế số một của Keytruda trên thị trường toàn cầu 

Trong vòng một thập niên, Keytruda (Pembrolizumab) của Merck đã tạo nên kỷ lục hiếm có: doanh thu vượt 146 tỷ USD, trở thành thuốc ung thư bán chạy nhất thế giới.

https://tinmoitrongngay2.wordpress.com/2025/11/13/%f0%9f%8c%bf-toan-canh-keytruda-thuoc-ung-thu-ban-chay-nh-at-the-gioi/

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nh ất thế giới

🌿 Toàn cảnh Keytruda – Thuốc ung thư bán chạy nhất thế giới 💖👉🍀🍀🤔 #ungthu #Keytruda #miendich #Merck #biosimilar #suckhoe 1️⃣ Vị thế số một của Keytruda trên thị trường toàn cầu 

Trong vòng một th…

Tin mới trong ngày
Global News BCAug 9, 2024
B.C. woman fighting cancer denied immunotherapy drug due to trial period
Soledad Ronco struggled through chemotherapy while also receiving the immunotherapy drug Keytruda to keep the triple-negative breast cancer at bay.
#globalnews #Health #BCCancerAgency #Immunotherapy #Keytruda
https://globalnews.ca/news/10689293/bc-woman-cancer-denied-immunotherapy-drug/
B.C. woman fighting cancer denied immunotherapy drug due to trial period

Soledad Ronco struggled through chemotherapy while also receiving the immunotherapy drug Keytruda to keep the triple-negative breast cancer at bay.

Global News
Global NewsAug 9, 2024
B.C. woman fighting cancer denied immunotherapy drug due to trial period
Soledad Ronco struggled through chemotherapy while also receiving the immunotherapy drug Keytruda to keep the triple-negative breast cancer at bay.
#globalnews #Health #BCCancerAgency #Immunotherapy #Keytruda
https://globalnews.ca/news/10689293/bc-woman-cancer-denied-immunotherapy-drug/
B.C. woman fighting cancer denied immunotherapy drug due to trial period

Soledad Ronco struggled through chemotherapy while also receiving the immunotherapy drug Keytruda to keep the triple-negative breast cancer at bay.

Global News
Global News OkanaganAug 9, 2024
B.C. woman fighting cancer denied immunotherapy drug due to trial period
Soledad Ronco struggled through chemotherapy while also receiving the immunotherapy drug Keytruda to keep the triple-negative breast cancer at bay.
#globalnews #Health #BCCancerAgency #Immunotherapy #Keytruda
https://globalnews.ca/news/10689293/bc-woman-cancer-denied-immunotherapy-drug/
B.C. woman fighting cancer denied immunotherapy drug due to trial period

Soledad Ronco struggled through chemotherapy while also receiving the immunotherapy drug Keytruda to keep the triple-negative breast cancer at bay.

Global News
cafepharmaMay 9, 2024
Keytruda strikes out again in endometrial cancer with phase III flop—Novo inks $600M deal with Metaphore to develop next-gen obesity drugs —Takeda Pharma to restructure after annual profit slump --http://bit.ly/w28kSd #merck #keytruda #endometrialcancer #clinicaltrials #novonordisk #obesity #drugdevelopment #takeda #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma
cafepharmaMar 21, 2024
Galderma sets IPO price at top of range—Merck combination treatment for lung cancer fails late-stage study—With executive shakeup and new pharma unit, Bayer's overhaul takes shape--http://bit.ly/w28kSd #ipos #galderma #merck #lungcancer #keytruda #clinicaltrials #bayer #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Cafepharma

Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.

Cafepharma